Panel Discussions

Applying Diagnostic Markers in Clinical Practice and Incorporating Updated Guidelines into Treatment Plans for CLL
with Dr. Martin Šimkovič and Dr. Romain Guieze and moderated by Dr. Othman Al-Sawaf

The webinar provided a comprehensive overview of the diagnosis and treatment guidelines for chronic lymphocytic leukemia, highlighting the importance of genetic factors and recent advancements in targeted therapies.

This video is CME accredited for 0.5 credits (30 min).

00:33 - Focus on Diagnostics: Overview of diagnostic criteria for CLL.

01:53 - Peripheral Blood Smear: Characteristics of lymphocytes in CLL.

02:59 - Flow Cytometry: Importance of immunoflow results in diagnosis.

02:21 - Differential Diagnosis: Other causes of lymphocytosis.

05:18 - Monoclonal B Cell Lymphocytosis (MBL): Criteria and risk of progression to CLL.

07:40 - Modern Scoring Systems: CLL-IPI and its importance.

10:22 - Imaging Studies: Role of CT and PET scans in CLL management.

13:49 - Updated Treatment Guidelines: Overview of current treatment options.

16:57 - First-Line Therapy: Preferred regimens for patients without TP53 alteration.

24:28 - Relapsed Patients: Treatment options for patients with prior exposure to BTK and BCL2 inhibitors.

27:28 - Discussion and conclusions: summary of main highlights.

How would you rate this content?

This site is only for use by healthcare professionals.

By continuing to view this site you are confirming that you are a healthcare professional.

Confirm